Evidence map›Paper›PMID 32093703›Full record

ArticlePediatric rheumatology online journal2020

Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children.

Rocío Galindo-Zavala, Rosa Bou-Torrent, Berta Magallares-López, Concepción Mir-Perelló, Natalia Palmou-Fontana, Belén Sevilla-Pérez, Marta Medrano-San Ildefonso, Mª Isabel González-Fernández, Almudena Román-Pascual, Paula Alcañiz-Rodríguez and 3 more

Open access · goldAbstract readConsensus Statement
In one paragraph

Article in Pediatric rheumatology online journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Bisphosphonates for osteoporosis in people with cystic fibrosis.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Fracture nonunion and delayed union.Journal of the Pediatric Orthopaedic Society of North America · 2024
    Article
  18. Article
  19. Pediatric and adult osteoporosis: a contrasting mirror.Annals of pediatric endocrinology & metabolism · 2024
    Article
  20. Bone fragility and osteoporosis in children and young adults.Journal of endocrinological investigation · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 1 country.

Rocío Galindo-ZavalaUGC Pediatría. Sección Reumatología Pediátrica, Hospital Regional Universitario de Málaga, Málaga, Spain. rociogalin@hotmail.com.ORCID http://orcid.org/0000-0002-0595-2153
Rosa Bou-TorrentUnidad de Reumatología Pediátrica, Hospital Sant Joan de Déu, Barcelona, Spain.
Berta Magallares-LópezServicio de Reumatología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Concepción Mir-PerellóUnidad de Pediatría, Sección Reumatología Pediátrica, Hospital Universitari Son Espases, Palma de Mallorca, Spain.
Natalia Palmou-FontanaUnidad de Reumatología, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Belén Sevilla-PérezUGC Pediatría, Sección Reumatología Pediátrica, Hospital Campus de la Salud, Granada, Spain.
Marta Medrano-San IldefonsoUnidad de Reumatología, Hospital Miguel Servet, Zaragoza, Spain.
Mª Isabel González-FernándezUnidad de Pediatría, Sección de Reumatología Pediátrica, Hospital La Fe, Valencia, Spain.
Almudena Román-PascualUnidad de Reumatología, Hospital General de Villalba, Madrid, Spain.
Paula Alcañiz-RodríguezUnidad de Pediatría, Sección de Reumatología Pediátrica, Hospital Virgen de la Arriaxaca, Murcia, Spain.
Juan Carlos Nieto-GonzalezServicio de Reumatología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Mireia López-CorbetoServicio de Reumatología Hospital Vall d'Hebron, Barcelona, Spain.
Jenaro Graña-GilServicio de Reumatología, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
Complexo Hospitalario Universitario A Coruña · ESHospital de Sant Pau · ESHospital General Universitario Gregorio Marañón · ESHospital Regional Universitario de Málaga · ESHospital Sant Joan de Déu Barcelona · ESHospital Universitario Miguel Servet · ESHospital Universitario Son Espases · ESHospital Universitario Virgen de la Arrixaca · ESMarqués de Valdecilla University Hospital · ESParque Tecnológico de la Salud · ESVall d'Hebron Hospital Universitari · ES

Funding

Alexion Pharmaceuticals 300Laboratorios Rubió 500
6 · The paper itself

Abstract

backgroundOsteoporosis incidence in children is increasing due to the increased survival rate of patients suffering from chronic diseases and the increased use of drugs that can damage bones. Recent changes made to the definition of childhood osteoporosis, along with the lack of guidelines or national consensuses regarding its diagnosis and treatment, have resulted in a wide variability in the approaches used to treat this disease. For these reasons, the Osteogenesis Imperfecta and Childhood Osteoporosis Working Group of the Spanish Society of Pediatric Rheumatology has sounded the need for developing guidelines to standardize clinical practice with regard to this pathology.

methodsAn expert panel comprised of 6 pediatricians and 5 rheumatologists carried out a qualitative literature review and provided recommendations based on evidence, when that was available, or on their own experience. The level of evidence was determined for each section using the Oxford Centre for Evidence-based Medicine (CEBM) system. A Delphi survey was conducted for those recommendations with an evidence level of IV or V. This survey was sent to all members of the SERPE. All recommendations that had a level of agreement higher or equal to 70% were included.

resultsFifty-one recommendations, categorized into eight sections, were obtained. Twenty-four of them presented an evidence level 4 or 5, and therefore a Delphi survey was conducted. This was submitted electronically and received a response rate of 40%. All recommendations submitted to the Delphi round obtained a level of agreement of 70% or higher and were therefore accepted.

conclusionIn summary, we present herein guidelines for the prevention, diagnosis and treatment of secondary childhood osteoporosis based on the available evidence and expert clinical experience. We believe it can serve as a useful tool that will contribute to the standardization of clinical practice for this pathology. Prophylactic measures, early diagnosis and a proper therapeutic approach are essential to improving bone health, not only in children and adolescents, but also in the adults they will become in the future.

Indexed as

Absorptiometry, PhotonAutoimmune DiseasesBone Density Conservation AgentsCalciumCystic FibrosisDelphi TechniqueDiphosphonatesEndocrine System DiseasesEpidermolysis BullosaGlucocorticoidsHematologic DiseasesHIV InfectionsHumansIatrogenic DiseaseKidney DiseasesMetabolism, Inborn ErrorsBone Density Conservation AgentsCalciumDiphosphonatesGlucocorticoidsVitamin DChildrenLow bone mineral densitySecondary osteoporosis

Identifiers

PMID32093703
PMCPMC7041118
OpenAlexW3010780464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.